With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting Fusion-driven Sarcomas||National Institutes of Health / Javed Khan, MD||Crazy 8 Initiative||2019||Maryland|
|Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis||Duke University / Corinne Linardic, MD/PhD & Yarui Diao, MD/PhD||Innovation Grants||2019||North Carolina|
|Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth||Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD||Crazy 8 Initiative||2019||Massachusetts|
|Saturating CRISPR gene body scans in MLL-rearranged leukemia||Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD & Lu Yang, PhD||Innovation Grants||2019||California|
|Targeting MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD||Crazy 8 Initiative||2019||Pennsylvania|
|Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease||St. Jude Children's Research Hospital / Linda Hendershot, PhD||Innovation Grants||2019||Tennessee|
|Investigating phase separated condensates in FPD to MDS/AML progression||Broad Institute / Zuzana Tothova, MD/PhD||RUNX1 Early Career Investigator Grants||2019||Massachusetts|
|Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs||University of Alberta / Hasan Uludag, PhD, Joseph Brandwein, PhD & Xiaoyan Jiang, MD/PhD||Innovation Grants||2019||Alberta|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia||St. Jude Children's Research Hospital / Charles Mullighan, MD/PhD, Hiroki Yoshihara, MD/PhD & Chunxu Qu, PhD||Innovation Grants||2019||Tennessee|